Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8576893rdf:typepubmed:Citationlld:pubmed
pubmed-article:8576893lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0596382lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0231174lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1882141lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:8576893lifeskim:mentionsumls-concept:C1549054lld:lifeskim
pubmed-article:8576893pubmed:issue10lld:pubmed
pubmed-article:8576893pubmed:dateCreated1996-3-14lld:pubmed
pubmed-article:8576893pubmed:abstractTextWe randomised ambulatory men with diastolic blood pressure (BP) 95-109 mmHg without anti-hypertensive medication to single drug treatment with either hydrochlorothiazide 12.5-50 mg/day, atenolol 25-100 mg/day, captopril 25-100 mg/day, clonidine 0.2-0.6 mg/day, diltiazem-SR 120-360 mg/day, prazosin 4-20 mg/day or placebo in a double-blind prospective trial. The assigned drug was titrated to a goal BP of < 90 mm Hg. Patients not achieving goal BP were rerandomised to an alternative single active drug. Non-responders to the second drug received the first drug in combination with the second. Of the 102 non-responders to both drugs who qualified for the combination, 59 (57.8%) responded. The combination pairs that included a diuretic achieved diastolic goal BP in 69% and < 140 mm Hg systolic in 77% compared with 51% and 46%, respectively, for those combinations without a diuretic (P = 0.067; P = 0.002). Six of the eight terminations due to adverse drug reactions were in combinations containing prazosin; three of these six were hypotensive reactions. We conclude that two single drugs of insufficient efficacy to control BP individually have a high probability of achieving goal BP when combined, especially if the combination contains a diuretic.lld:pubmed
pubmed-article:8576893pubmed:languageenglld:pubmed
pubmed-article:8576893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8576893pubmed:citationSubsetIMlld:pubmed
pubmed-article:8576893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8576893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8576893pubmed:statusMEDLINElld:pubmed
pubmed-article:8576893pubmed:monthOctlld:pubmed
pubmed-article:8576893pubmed:issn0950-9240lld:pubmed
pubmed-article:8576893pubmed:authorpubmed-author:HendersonW...lld:pubmed
pubmed-article:8576893pubmed:authorpubmed-author:MatersonB JBJlld:pubmed
pubmed-article:8576893pubmed:authorpubmed-author:CushmanW CWClld:pubmed
pubmed-article:8576893pubmed:authorpubmed-author:SasuA MAMlld:pubmed
pubmed-article:8576893pubmed:issnTypePrintlld:pubmed
pubmed-article:8576893pubmed:volume9lld:pubmed
pubmed-article:8576893pubmed:ownerNLMlld:pubmed
pubmed-article:8576893pubmed:authorsCompleteYlld:pubmed
pubmed-article:8576893pubmed:pagination791-6lld:pubmed
pubmed-article:8576893pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:meshHeadingpubmed-meshheading:8576893-...lld:pubmed
pubmed-article:8576893pubmed:year1995lld:pubmed
pubmed-article:8576893pubmed:articleTitleResults of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents.lld:pubmed
pubmed-article:8576893pubmed:affiliationDepartment of Veterans Affairs, Cooperative Studies Program Coordinating Center, Hines, IL, USA.lld:pubmed
pubmed-article:8576893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8576893pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8576893pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8576893pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8576893pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8576893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8576893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8576893lld:pubmed